scispace - formally typeset
C

Christopher G. Scott

Researcher at Mayo Clinic

Publications -  381
Citations -  24294

Christopher G. Scott is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 60, co-authored 316 publications receiving 19468 citations. Previous affiliations of Christopher G. Scott include University of Rochester & University of Michigan.

Papers
More filters
Journal ArticleDOI

Burden of valvular heart diseases: a population-based study.

TL;DR: In this paper, the authors assess the prevalence and effect of valve disease on overall survival in the general population and find that moderate or severe valve disease is common in this population and increase with age.
Journal Article

Burden of valvular heart diseases : a population-based study. Commentary

TL;DR: Moderate or severe valvular heart diseases are notably common in this population and increase with age and in the community, women are less often diagnosed than are men, which could indicate an important imbalance in view of the associated lower survival.
Journal ArticleDOI

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou, +396 more
- 02 Nov 2017 - 
TL;DR: A genome-wide association study of breast cancer in 122,977 cases and 105,974 controls of European ancestry and 14,068 cases and 13,104 controls of East Asian ancestry finds that heritability of Breast cancer due to all single-nucleotide polymorphisms in regulatory features was 2–5-fold enriched relative to the genome- wide average.
Journal ArticleDOI

Quantitative determinants of the outcome of asymptomatic mitral regurgitation

TL;DR: Quantitative grading of mitral Regurgitation is a powerful predictor of the clinical outcome of asymptomatic mitral regurgitation and patients with an effective regurgitant orifice of at least 40 mm2 should promptly be considered for cardiac surgery.
Journal ArticleDOI

Outcome of 622 Adults With Asymptomatic, Hemodynamically Significant Aortic Stenosis During Prolonged Follow-Up

TL;DR: Most patients with asymptomatic, hemodynamically significant AS will develop symptoms within 5 years, and age, chronic renal failure, inactivity, and aortic valve velocity are independently predictive of all-cause mortality.